Twenty-two points to consider for clinical trials in systemic sclerosis, based on EULAR standards

Objective. SSc is clinically and aetiopathogenically heterogeneous. Consensus standards for more uniform trial design and selection of outcome measures are needed. The objective of this study was to develop evidence-based points to consider (PTCs) for future clinical trials in SSc. Methods. Thirteen...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Rheumatology (Oxford)
Main Authors: Khanna, Dinesh, Furst, Daniel E., Allanore, Yannick, Bae, Sangmee, Bodukam, Vijay, Clements, Philip J., Cutolo, Maurizio, Czirjak, Laszlo, Denton, Christopher P., Distler, Oliver, Walker, Ulrich A., Matucci-Cerinic, Marco, Müller-Ladner, Ulf, Seibold, James R., Singh, Manjit, Tyndall, Alan
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2015
Assuntos:
Clinical Science
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4269793/
https://ncbi.nlm.nih.gov/pubmed/25125594
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rheumatology/keu288
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados